text:
Register now for free, or sign in with any of these services:
Diegodiego Makes his debut singing in English with new Single "Feeling The World" It's been long waited for, but it finally makes its debut,. Diegodiego's all new English music single. "Feeling The World" was released to the world wide web and you can listen to it now. The dance song is Diegodiego's first release after five years of his last album in Spanish. But as Hollywood and the world has made of Diegodiego a household name. The star was expected to release an all english album. This one entitled "The World's Most Powerful Man". The new song was co written and composed by Nicholas Lopez and produced by the star's record label American Entertainment. "Feeing The World" The first single from the album will be available for download on Itunes.com, Amazon.com and other music websites on July 6th, 2012. But you don't have to wait till then. You can listen to the track now. From the World's Number one entertainer and now World's most powerful man we present to you "Feeling the world' by Diegodiego.


text:
AFP Announces New Chapters
The new Massachusetts Central Chapter serves the Worcester area and named Janet L. Hedrick president. Hedrick is director of clinical campaigns at the University of Massachusetts Memorial Foundation.
The new Virginia Hampton Road Chapter serves the Norfolk, Hampton and Virginia Beach areas and has named Robin Deal president. Deal is director of development and donor services at The Norfolk Foundation.
The addition of these chapters brings AFP's total chapter count in North America to 161

subset: commoncrawl


text:
UK Newspaper Editors Side With Cameron Opposing Media Regulation By Law
Category: Society
/ Nov 29, 2012 5:08PM EDT
British newspaper editors kicked back on Thursday (November 29) against a Leveson report recommendation for a press watchdog backed by law . The Leveson inquiry into media ethics was triggered by the phone hacking scandal. Newspapers are generally in favor of an independent press regulator, but do not agree with it being underpinned by law. Bob Satchwell, Executive Director of the Society of Editors, said such a move could restrict freedom of the press. "As soon as you have some law that is specific to the press that's when it infringes on press freedom," Satchwell said. "What we are saying is that journalists and the press should not have any special laws other than the ones which we are all subject to as citizens and that's where the danger lies, that's where the undermining of freedom of expression and freedom of the press can come in." Paul Connew, former editor of the tabloid Sunday Mirror, does not agree with the law despite having been a victim of phone-hacking himself. "They've taken a dangerous step, or potentially dangerous step back in time. And I also think internationally it sends out a rather negative message to journalists and citizens in countries where you have regimes with appalling human rights records," Connew said. "In those countries individuals and journalists have looked up to the press for all its faults and all its raucous tabloids, but broadly speaking the British press is a free press, they refer to it as the great free press of the world and I think this is a retrograde step," he said. Shortly after the Leveson report was released, Prime Minister David Cameron told parliament he had serious concerns about legislation to regulate the media. His stance will delight British media ahead of the 2015 election, but has angered victims of phone-hacking and will deepen a divide in Cameron's coalition government and within his own party.
Feb 19, 2016 1:53PM
Feb 19, 2016 12:52PM
Feb 19, 2016 12:44PM
Feb 19, 2016 12:33PM
Feb 19, 2016 12:32PM
Feb 19, 2016 11:53AM
Feb 19, 2016 11:32AM
Feb 19, 2016 10:58AM
Feb 18, 2016 10:47PM
Feb 18, 2016 9:52PM


text:
The Buffalo Bills travel to face the Kansas City Chiefs in the 2011 NFL season opener. The contest marks the 10-year anniversary of 9/11, and special tributes will be conducted at stadiums around the league. Kickoff is at 1:00 EDT, and the game will air on CBS. The Chiefs are favored in this game by 5.5 points, and the over/under is 40.5 points.
The Chiefs won the AFC West in 2010 with a 10-6 record and are attempting to prove that it was not a fluke. The Chiefs offense is headed up by quarterback Matt Cassel, running backs Jamaal Charles and Thomas Jones and wide receiver Dwayne Bowe. The Chiefs had the No. 1 rushing offense in the NFL in 2010, as they averaged 164.2 rushing yards per game.
The Chiefs defense is led by Tamba Hali, who finished second in the NFL in 2010 with 14.5 sacks. The Chiefs defense was ranked 14th in the NFL in 2010.
The Chiefs have some issues coming in to this game. Cassel is playing with a cracked rib, as he was injured in the final preseason game against the Green Bay Packers. In that game, the Chiefs lost starting tight end Tony Moeaki for the year due to a torn ACL. In addition, first-round draft pick Jonathan Baldwin is out due to surgery on his thumb. Baldwin hurt his thumb due to a locker room fight with Thomas Jones.
The Bills finished the 2010 season tied for the worst record in the AFC at 4-12 with Cincinnati and Denver. The Bills completed their first year under the leadership of GM Buddy Nix, head coach Chan Gailey and defensive coordinator George Edwards. The Bills switched to a 3-4 defensive scheme in 2010 and struggled to find a way to to stop the run. The Bills rush defense was the worst in the NFL, as they allowed a whopping 169.6 yards per game.
The Bills visited the Chiefs in 2010 in Week 8, where the Bills lost a heartbreaker in overtime, 13-10. In that game, Jamaal Charles rushed 22 times for 177 yards, averaging eight yards per carry. Despite his performance, the Chiefs struggled in third down conversions, going 4-15, while the Bills converted 11-23 in the game.
The Bills have been rebuilding their franchise in the past year. Gone are players like Trent Edwards, Marshawn Lynch, Paul Posluszny, Donte Whitner, Aaron Maybin and Lee Evans. The Bills had a solid draft class in 2011, highlighted by defensive lineman Marcell Dareus and corner Aaron Williams. The Bills signed Pro Bowlers Kyle Williams and Shawne Merriman to new contracts and brought in veteran free agent linebackers Nick Barnett and Kirk Morrison to shore up the run defense.
Based on the preseason games, the Bills' front seven on defense looks to be bigger, stronger and more aggressive. The key to this game is shutting down Jamaal Charles on the ground and forcing Cassel to throw the ball, where the Bills' improved pass rush hopes to get some hits on him and knock him out of the game. On offense, the Bills have added free agent quarterbacks Tyler Thigpen and Wildcat specialist Brad Smith to add some new dimensions to the team. Should be a tight, hard-fought contest.


text: Jaguars' 2011 Season Analogy Posted by Shane Clemons on Nov 2, 2011 05:30 ShareTweet I can't think of a better way to sum up this season. ShareTweet About Shane Clemons Shane Clemons came from humble beginnings creating his own Jaguars blog before moving on to SBNation as a featured writer for the Jaguars. He then moved to Bloguin where he briefly covered the AFC South before taking over Bloguin's Jaguars blog. Since the inception of This Given Sunday, Shane has served as an editor for the site, doing his best not to mess up a good thing. View all posts by Shane Clemons → | Twitter


text:
Top Definition
That babe by the bar is totally porkable, man!
di Tailspin 18 ottobre 2003
Trending Now
Can you define these popular missing words?
one who has the looks to be porked
wow look at her she is so hot and porkable
di incredible1 11 luglio 2012
"What about that one there?" "Where?" "there by the bar" "oh year, cor' she's porkable"- To think or say to a chum, i wouldnt mind fucking that bird, she's porkable
di Fatcoins 03 febbraio 2009


text:
Nintendo's handheld Nintendo 3DS, afterjust four months on the market soon much cheaper.The hardware vendorhas announced that the 3DS already from 12 August in the U.S. for169.99 U.S. dollars instead of the current for 249 U.S. dollars willbe available. In Japan, the price falls back on 11 for 3DS Augustfrom 25,000 yen to 15,000 yen. In Europe, the 3DS in the context ofthe "global price-cutting initiative" cheaper. How muchexactly will not betray Nintendo - Nintendo talks about a pricereduction to "about one-third," the 12th August. Currentlycosts between 199 € the 3DS and 219 €. .We expect a suggestedretail price of 130-150 € in mid-August , the president of Nintendoof America, Reggie Fils-Aime said the price cut: "For everyonewho was still undecided whether he should buy a Nintendo 3DS, Nowthat a big motivation to strike.
Nintendo has considered a strategy toattenuate the possible outrage at the early discount for those whohave already purchased the 3DS to the original price. In theso-called "3DS Ambassador Program" (3DS Ambassador program)will receive all who already have a 3DS or until the price reductionon 12 August to buy one game classic gift.
Who with his 3DS up to and includingthe 11th August in Nintendo eShop logs receives the first September,a package of 10 free NES Virtual Console games (including Super MarioBros., The Legend of Zelda and Donkey Kong Jr.).These are for themajority of the players available until later. be the end of 2011hosted a series of games for the Game Boy Advance Virtual Consolewill appear, including Yoshi's Iceland, Super Mario Advance 3, MarioKart, Metroid Fusion uvw.


text:
MLB: Blue Jays' McGowan Earns First Win Since 2008
Toronto Blue Jays' Dustin McGowan hasn't pitched in a while. He also hasn't won in a while either. McGowan waited six years due to multiple injuries to be able to win his first game since 2008.
For more information on this story visit: Hardball Talk, Bill Baer


text:
on February 21, 2013 - 10:23 PM
LOCKPORT – The city is in the market for a part-time assessor after Joseph Macaluso said Thursday he is retiring, effective March 28.
Macaluso, a Batavia resident who is retired from the state Office of Real Property Services, took over the city assessor's office in April 2009 and has generally worked two days a week. His salary this year was to have been $20,607.
"We're not going back to a full-time assessor," Mayor Michael W. Tucker said. "We've proven we can run without a full-time assessor."
Macaluso said he will be 62 on April 3 and has applied for Social Security benefits, which limits the amount of money he can earn without penalty to about $14,500 a year. "I am going to work part time at the Batavia Country Club," he said. This summer, he will be doing the bookkeeping. "I figure turning 62, it was a good time to say, 'That's enough,' " Macaluso said. "We are planning on a 2014 update, so the city needs to look forward."
In 2011, Macaluso presided over the city's first full-scale reassessment in a decade and placed the city on a three-year schedule of citywide revaluations.
The reassessment was done with the help of a consulting firm, but Tucker said the city is required to name someone as assessor to meet the legal requirement of signing the annual tax roll. He said the city could hire a company to perform much of the work, because the city negotiated the assessor title out of the department head union several years ago.
Tucker said it doesn't look like the city will be able to make a deal to share an assessor with another municipality, as Wilson and Niagara Falls do. He said he talked to Town of Lockport Supervisor Marc R. Smith about sharing, but it doesn't seem like the timing is right. "I've always hoped to share assessment services with the Town of Lockport. Their assessor out there [Jill Lederhouse] is relatively new," he said.
Lederhouse was hired in December 2011 after having served as acting assessor since March 2011 and deputy assessor before that. Tucker said he had hoped to share the services of her predecessor, John E. Shoemaker, but when he left the town to become Niagara County real property services director, the plan was sunk.
email: email@example.com


text:
Samsung's "It doesn't take a genius" ad parodied by Apple iPhone supporters
0. phoneArena 16 Sep 2012, 10:20 posted on
Samsung's new ad comparing the features on its flagship Samsung Galaxy S III with those on the Apple iPhone 5 has touched a chord among Apple iPhone fans who have responded with some parodies of the Samsung ad...
This is a discussion for a news. To read the whole news, click here
92. rusticguy (Posts: 2828; Member since: 11 Aug 2012)
Much in line with Apple philosophy the followers just stole the ad made cosmetic changes and called it their own ... what a makred similarity in thought process :D
93. Just_Root_it (Posts: 7; Member since: 16 Sep 2012)
Apple = A prank phone leader in Economy...take that
95. jibraihimi (Posts: 761; Member since: 29 Nov 2011)
I think only chink in Samsung's armour now is their continous use of cheap plastics in their flagship phones............ Samsung should change it's strategy with their next flagship phone, and should use premium materials atleast for their flagships............... And ya samsung we expect better design from you next time............
96. jibraihimi (Posts: 761; Member since: 29 Nov 2011)
Though iFans are defending iPhone 5 with all their might, but inside their heart they are also feeling let down by the launch of 'iPhone 4S stretched'........... I have visited many apple centric sites and blogs and have seen comments of many iFans. Over there, and majority of them were sad and angry on Apple for releasing just a incremental update over iPhone 4s.............
98. Jynto (Posts: 1; Member since: 16 Sep 2012)
In the interest of balance and neutrality, I've created the final version of this table to show how pointless this fanboy war really is.
lbums/h366/Jynto/BattleoftheSm artphones_.jpg
I tried to find more features for the iPhone, so I found they came out roughly equal. I also added metric conversions to the measurements, and removed all mentions of 'HD' from both. I took away minor features like 'tilt to zoom' from the Galaxy, because I'm sure the iPhone has plenty of those too. Some of it was based on Alex Schot's modification. I also included the most important (to some people) feature. And yes, you can play Angry Birds on both.
Feel free to share this around the internet.
107. protozeloz (Posts: 5396; Member since: 16 Sep 2010)
fair enough, you must have added that android has integration with any social network as long as there is an app for it
123. BattleBrat (Posts: 1457; Member since: 26 Oct 2011)
Hmmm social network support was built into my RAZR, no apps needed, you just log in.
Your work on the parody was clean, no artifacts, good work!
134. kew01 (Posts: 15; Member since: 28 Jul 2012)
I like how you added an extra line to the iPhone's list just to have it bigger than Samsung's. A non feature ofc, what else ;).
99. JunkCreek (Posts: 407; Member since: 13 Jul 2012)
Everyone, this is NOT iPhone 4S-tretched but THIS IS iPhone 5-tretched. Please at least, respect to the given name!
101. regkilla (Posts: 83; Member since: 13 Sep 2012)
Quad Core or Dual Core? Make up your minds already!
105. rusticguy (Posts: 2828; Member since: 11 Aug 2012)
They cannot differentiate .. Apple keeps saying repeatedly :D
102. abhijeit (Posts: 25; Member since: 07 Sep 2012)
If apple is sooo much interested in the looks department, den the award undoubtedly goes to Nokia N9, or Lumia 920!!!! STFU apple...same design every year huh!!! WTF do u do throughout the year...y dont u design ur product instead of designing plans for suing people!!!!
104. RORYREVOLUTION (Posts: 3108; Member since: 12 Jan 2010)
Just to make it clear, I plan on getting the iPhone 5! As a back up phone for my SGS3. Lol
108. djripster (Posts: 138; Member since: 10 Dec 2011)
:) Not the greatest combacks
109. justaphone (Posts: 6; Member since: 19 Aug 2012)
IPhone 5 - 1601
So much for the spec sheet....
135. kew01 (Posts: 15; Member since: 28 Jul 2012)
I wonder how can they compare a phone optimised for QUAD CORE with a phone optimised for DUAL CORE in a DUAL CORE Benchmark?
Or maybe I don't understand how that benchmark works?
And wasn't that S3's score for ICS and not for JB? I think I've read somewhere that with JB, S3 scored over 1700.
113. nwright94 (unregistered)
To all the people saying it: there is not just 450k apps for the iPhone. There's 700k. The 250k apps made for iPad are a standalone number, not subtracted from that 700k. No one remembers when apple heralded 500k apps passed for iPhone? So did they all the sudden lose 50k apps? Use your brains people. But other than that most things everyone is saying is accurate, just not the apps. Don't try to twist around facts, even if you dislike the phone. Now I'm just waiting for my lumia to get more than 100k apps :)
122. doejon (Posts: 398; Member since: 31 Jul 2012)
what will the ifanboys will do if the galaxy s4 next year will come
in alu kevlar unibody? hahaha looking forward to hear realy silly nonsense
s3 is the winner
130. c.hack (Posts: 609; Member since: 09 Dec 2009)
I think you just have to read your posts to hear the really silly nonsense.
124. MrNobodyWTB (Posts: 27; Member since: 03 Jan 2012)
Once again Apple fanboys go crazy over fact and try to market theirs as technically superior, when they can't even get a basic technical specification right.
Fans of apple have even been raving about their "totally different plug" having host capabilities and the abiliity to now hook up keyboads, mice etc. when other phones have had that capabliity for a while now.
131. soullinker20 (Posts: 5; Member since: 16 Sep 2012)
i'm an iphone user but I would not say it is superior than the s3 .. design wise it's a close call for me. but i have yet to decide which to purchase.. if the batt life of the s3 is on par or much better than the ip5 on a 2G then i'll take it!
anyway how long does the batt of the s3 last compare to ip4s
133. mib1800 (Posts: 1; Member since: 17 Sep 2012)
SGS3 vs IP5
IP5 MISSING ALL of following:
- bigger 4.8in + AMOLED screen
- storage upto 96GB (32Gb + 64Gb external)
- removable battery
- better 2MP front camera + more functional camera app
- USB To Go (direct connect to portable drive, keyboard, game controller, usb-hub etc)
- unrestricted BlueTooth
- Wifi-Direct
- DLNA / Allshare / AllCast
- NFC - direct share/beam, automate phone tasks with TecTiles/tags, NFC payment
- HDMI out (video and UI)
- standard USB-port (no need for proprietary and expensive adapters/cables)
- One touch dial/sms (via desktop shortcuts) + Speed dial with phone keypad
- Picture contact/log (incl. grid view) and unlimited call log
- contact sync/integration with fb,tw,skype,g+ etc
- 3G-standard video call
- Motion: Flip to silent, Pick-to-call, Touch for missed call/sms, Tilt to zoom, double-tap to scroll
- multi-purpose LED indicator
- Smart Stay (keep screen on via face detection)
- Built-in call-blocker (to keep away unwanted calls)
- Unrestricted internal storage access via USB (or other connectivity methods)
- File-system
- Full email attachment support
- various desktop launcher UI to cater to any taste
- Widgets (one-glance for essential info)
- Live Wallpaper (aesthetic)
- Lock Screen direct launch
- Quick Toggles in Notification
- Full Multi-Tasking
- Back button for easier back navigation (+ reduces screen space wastage)
- Replaceable keyboard (swype/T9/variants etc)
- Non-centralized settings :p
- Various media format support (avi, divx, mkv etc) - no need for tedious itunes conversion
- Popup-Play
- Web-broswer text reflow (+Flash support)
- UI Font Type/Size selection
APPS (not possible for IOS due to limitations/restrictions)
- Side-loading of apps + browser-based app installation
- Better Google-based services/apps
- Free 50GB drop-box storage
- Plug-and-Play (seamlessly replace built-in apps with 3rd party)
- Intents (manually choose which installed app to launch based on content-type)
- Automation-type apps e.g.
o automaticly switch phone settings (vol, bt, wifi etc) based on events/states/gps/nfc
o phone call recording
o NFC tasks (tectiles) - e.g. tap to call/sms directly (or change phone settings)
o schedule auto send sms/email based on events (birthday, meeting reminders etc)
o auto check-in, auto upload photos/info
136. kew01 (Posts: 15; Member since: 28 Jul 2012)
Oh snap... you just won the interwebs!
I tip my hat in respect. Have a nice day my good Sir, have a nice day.
162. flamencoguy (Posts: 107; Member since: 04 Aug 2012)
Not to mention expensive non-std non-USB connection for charging and data transfer. Locks you in to their products so they can GOUGE you. EU has mandated that microUSB to be the mobile std for charging and data transfer
139. E34V8 (Posts: 84; Member since: 16 Dec 2011)
IFans don't even know their own hardware :) . A6 QuadCore lol !
152. b3roldan (Posts: 3; Member since: 18 Sep 2012)
I had to scratch my head on that one... always figured it was only DualCore. But giving Apple the benefit of the doubt ... quad-core 1Ghz is still lower than 1.4Ghz SGSIII.
161. flamencoguy (Posts: 107; Member since: 04 Aug 2012)
A6 is dual core base on ARM A15
141. app_droid_soft (Posts: 42; Member since: 09 Sep 2012)
android folks buy galaxy s3 and settle for cheap plastic...cheapos!
142. whysoserious (Posts: 318; Member since: 20 Jul 2012)
Apple folks buy iPhone 5 and settle for an erected version of iPhone 4...lame!
158. flamencoguy (Posts: 107; Member since: 04 Aug 2012)
It's what's inside that counts! Just like what is in between your ears. Tell me you don't have any plastic anywhere in your home or car?
Metal impedes radio signals. Not the best material for Wifi or phone reception. And maybe we are just smart shoppers who aren't dumb enough to give away money for the perceived status symbol. Maybe iFolks are even insecure and need a crutch to make you feel worthy.
150. b3roldan (Posts: 3; Member since: 18 Sep 2012)
I agree that it is not necessarily a Spec game, I'm still using my good old Galaxy S2 and did not jump for the latest gadgets out there this year and am still able to experience all the features in the S3 with the exception of the NFC because that is hardware based. Apple has to market their product with a focus on the user experience over specs because they know they didn't cut it in terms of being leading-edge in technology.
The ONLY improvements Apple should be able to claim over the old iPhone is the screen size and LTE. Both of which were already claimed milestones by the competition.
For the rest (Siri, Face detection, Panorama, video stabilization, Take still photos while recording, EarPods) are all in the software and CAN be implemented to older iPhones. Apple patrons should be miffed and unpleased with the fact that Apple left them behind and is forcing them to upgrade. I would be surprised if they improved Siri and Apple Maps and made it exclusive to iPhone5s or iPhone 6. Apple patrons... be ready for this.
Deciding to get either an Android or Apple smartphone requires much deliberation because once you have spent much of your hard-earned cash on Apps, you are more inclined to stay with the respective market. If you have spent hundreds or thousands on apps purchased in the Apple app store, I doubt you'd allow yourself to throw all that away buy jumping ship to Android and vice versa.
I would pick the iPhone generally because of its metallic feel and user interface. The reason I won't get one is because I would like to have full control of whatever I buy. Its mostly Apple's business model and restrictive environment that I choose not to purchase the iPhone.
My Reasons:-
(1) Apple abandons its patrons and forces them to upgrade their phone even though they shouldn't have to. (Example: The iPhone 4 and earlier models don't have Siri when they are fully capable of having the feature)
(2) Other brands allow you to plug your smartphone to any computer via USB and copy your music, data and films without the need to install any software/app like iTunes. It is that easy!
(3) Brands such as HTC, Blackberry & Samsung use the standard USB cable to plug & charge their devices. Apple products force you to use their own plug. Not to mention all those Apple patrons who have bought previous Apple phones and iPhone/iPad compatible speakers will now HAVE TO BUY a converter to make those products compatible with the new iPhone5
(4) When you purchase music through iTunes, you do NOT own it. You only purchase the "right" to listen to it on your Apple device. (i.e. Bruce Willis could not pass his vast music library to his children.)
(5) Limits iPhone user's battery choices. I upgraded the stock battery on my Galaxy S2 from a 1650mAh to a 3800mAh. And it could be done in less than 10seconds. Not to mention it comes with a built in stand so I could watch movies all day long.
159. flamencoguy (Posts: 107; Member since: 04 Aug 2012)
congrats. You are very knowledeable. My hats off to you.
151. b3roldan (Posts: 3; Member since: 18 Sep 2012)
(6) Apple bullies other companies by forcibly dictating what features should not be included - Flash, NFC to name a few. So if you're an anime freak like me, forget about being able to watch those anime from websites still using Flash technology.
(7) Apple decided to use the slower LTE band on the iPhone5 which is on the 1800mhz spectrum and boasts a theoretical maximum bandwidth of 65M compared to the current standard 2600mhz which can easily achieve 100M. I won't be surprised if Apple screws it's loyal patrons again by releasing an iPhone 5s with NFC and faster LTE.
(8) I own a MacBookPro 13" (2011) edition. I had a simple problem, I experience corrupted textures when playing Diablo 3 (100% in Act 3). This is a known issue with the GPU drivers. If I were on Windows, I would just need to update the Graphics driver and it would be fixed. But for OSX, you will need to purchase and update the whole Operating System to Mountain Lion to fix that issue. Quite ridiculous and another stick up your butt being screwed by yours truly, Apple.
(9) Last but not least, let's talk about the iPhone5. Let me start by countering those "misleading specs put in iPhone5's favor.
- CPU: iP5 = Quad-Core 1Ghz (S3 = Quad-Core 1.4Ghz)
- Front-Screen Camera: iP5 = 720p (S2 & S3 = 1080p)
- iCloud (Any Android: Google Drive)
- Shared Photo Stream (erm... how's that different from instagram/facebook/kodak photo sharing?)
- Panorama (already existed in Sony Ericsson and Nexus phones since last year. Can be easily enabled on any SmartPhone including old iPhones by downloading panorama apps like Google's 360)
- 700,000 apps (Android 500,000)
- Passbook (This is a great idea, BUT it is software based and should be available also for older iPhones!)
- Free OS Updates Annually (Android: Same)
- FaceTime (C'mon... Skype allows you to chat with anyone using any device, why limit your interaction to Apple customers only?)
- All-New Maps with Flyover (Already existing in Google Maps)
- Airplay (This can already be done with other smartphone devices, in fact any device with Wifi/Blutooth. Apple will probably FORCE speaker manufacturers to only allow Apple devices via the "Airplay Brand")
- Sleek and Durable Aluminium Black (erm... that's not a feature and is subjective to each individual's preferences. Not necessarily a pro)
- Game Center (S3: Google Play, Samsung Apps, Game Hub... thse are 3 game markets!)
-iMessage (again... why limit your communication to ONLY Apple users when you can use Skype, WhatsApp, Voxer, Viber, Facebook Messenger to chat with anyone)
160. flamencoguy (Posts: 107; Member since: 04 Aug 2012)
+1 Like
153. Tillmoss (Posts: 1; Member since: 18 Sep 2012)
com/-bG3Rv-tb4KI/UFh_1UORWUI/AAAAAAAAAIA/ LFe4vQbHG1Q/s851/iphone+5.jpg
157. flamencoguy (Posts: 107; Member since: 04 Aug 2012)
What does iPhone 5 and Jimi Hendrix have in common?
Answer: Purple Haze.


text:
For readers who are not very familiar with the comic series, Wolverine is a mutant, possessing animal-keen senses, enhanced physical capabilities, retracting bone claws, and a healing factor that allows him to quickly recover from virtually any wound, disease or toxin, also enabling him to live beyond a normal human lifespan.
This healing ability enabled the supersoldier program Weapon X to bond the near indestructible metal alloy adamantium to his skeleton and claws without risk of killing him.
After seeing X-Men Origins, I could not help but think that Wolverine embodies the qualities that should be sought after in the remaking of the Arsenal team.


text:
Village of Mundelein
Village of Mundelein Waste Management and Recycling
Residents may choose from two types of refuse programs:
Unlimited Standard Level of Service:
Residents will have unlimited service with one 95 gallon cart for standard household waste collected weekly. Included in this service, Groot will also provide a 65 gallon cart for weekly collection of recyclables. Residents will be allowed to place one bulk item out per week at no additional charge. Refuse should be placed out to the curb by 6:00 a.m. on the day of collection. Groot will invoice the residents directly on a quarterly basis.
Pay-Per-Bag Program:
Residents who generate small volumes of refuse may elect the pay-per-bag program. In this program residents can purchase a refuse sticker and affix the sticker to each bag or can not to exceed 33 gallons containing standard household waste. Included in this service a 65 gallon cart will be provided for weekly collection of recyclables. *Please note: if your household generates more than one bag per week, it is more cost-effective to utilize the unlimited standard level of service.
Senior Program:
To be eligible for this program residents must be 65 years or older, service includes weekly collection for one 35 gallon cart for refuse and one 35 gallon cart for recycling. Seniors must register for the Village senior water rate in order to be eligible for the senior garbage rate. Any senior electing to utilize the 95 gallon cart will still be invoiced at the standard rate. Groot will invoice the residents directly on a quarterly basis.
Please note that both the unlimited and pay-per-bag refuse collection programs include a 65 gallon cart for recycling. Recycling service includes weekly collection of a 65 gallon cart.
Click here for a list of Recyclable Materials
Landscape Waste Program (Optional Program):
Residents will have landscape waste collection weekly from April 1st through November 30th. Grass clippings, leaves, twigs, garden debris, weeds, fruits, seeds, stalks, vines are acceptable landscape items. Landscape does not include wood timbers, plastic edging, plant pots or trays, fertilizer or landscape material bags, landscape fabric, root sections, sand, gravel, sod, firewood, rocks, bark, wood chips, excess amounts of dirt or animal waste. The two programs offered are as follows:
- Subscription Service: Residents who generate higher volumes of yard waste may elect to pay an annual fee for the collection of up to four approved containers weekly throughout the landscape waste season. Subscription fee must be paid in full upon signing up.
- Landscape Waste Stickers: Residents who have limited volumes of yard waste will have the option to purchase a sticker and place it on either a 33 gallon or smaller can or a biodegradable yard waste bag.
State Laws require us to collect any "white good" type of appliances such as refrigerators, ovens, washers, etc. separately and recycle. There is a fee per item for collection and you are required to call the office to schedule and make arrangements for payment.
Special Pick-ups and Extra Garbage:
If you find you need extra rubbish picked up all at one time there will be an extra charge per cubic yard and you must call the office to arrange for scheduling and payment. If you choose to have your clean-up done on a day other than your normal service day, an extra trip fee will be charged.
Bulk Items:
One bulk item such as a couch or dresser or 1 cubic yard (3' x 3' x 3') of miscellaneous debris or construction material will be collected each week for no additional charge. Construction type debris should be stacked or bundled in lengths no longer than 4 feet and no larger than 2 feet in diameter.
- We will consider a box spring and mattress as one large item
- Carpeting should be in rolls no longer than 4 feet long and 2 feet in diameter and taped. We consider 5 rolls to be one large item.
- In general try and keep any loose material bundled and neat so we can pick up.
- Stone, concrete, and dirt can only be picked up in containers and cannot weigh more than 45 lbs. per container. Two containers will be considered one large item.
Electronic Waste Collection - "e-waste":
The Illinois Electronic Products Recycling and Reuse Act prohibits any person from allowing or to cause mixing of any of the items listed with municipal waste that is intended for disposal at a landfill.
Groot Industries offers collection of these items directly from your home for an additional fee; however, you must call in advance to schedule a pick-up and make arrangements.
All items collected will be recycled and rendered inoperable. Due to the sensitive nature of some electronic items (computer hard drives or storage devices), we prefer to pick up items from the front, side, or top of drive locations.
Customers also have the option to bring their items directly to drop-off sites throughout the area, most of which are for no charge. Please visit the where and how page of our site and click on your county and then your town to search for area drop–off locations.
Oversized/Overweight Items:
Some items are just too big or heavy for our people to handle without special equipment, in that case your driver may leave it so special arrangements can be made. In this event special charges will apply. Please call and check first if you think what you have placed out falls in this category.
Tough Items:
Fluorescent bulbs, needles, paint; tires etc... create special problems, please click here for help.
Construction Demolition Debris:
All material must be cut to no more than 4 feet in length and no larger than 2 feet in diameter. All debris must be bagged or bundled and should not exceed 45 pounds. Residents will need to call Groot at (877) 404-7668 to obtain price quote and to schedule a pick-up.
Additional Cart Rental:
Residents who want two or more carts will need to call Groot to order and pay for the additional cart rental which will be billed on a quarterly basis.
Fall Leaf Vacuuming:
Residents can rake leaves to the curb from the third week of October through the first week of December.
Christmas Tree Pickup:
Residents may also place on the curbside, until January 31, their discarded Christmas trees for pick-up.
Yard Waste and refuse stickers may be purchased at the following locations:
- True Value | 516 N. Seymour | Mundelein
- Ace Hardware * | 609 E. Hawley | Mundelein
- Jewel | 1501 S. Lake St. | Mundelein
- Mundelein Village Hall | 440 E. Hawley | Mundelein
- Ace Hardware Libertyville | 155 Peterson Rd | Libertyville
- Walgreens | 951 N Highway 83
* Convenient payment drop box at this location.
Please call (877) 40-GROOT for more information on these programs.
Observed Holidays
- New Year's Day
- Labor Day
- Memorial Day
- Thanksgiving Day
- Independence Day
- Christmas Day
*If the holiday falls on a Saturday, pick up will stay the same.
*If the holiday falls on a Sunday, Monday will be an off day.
*If the holiday falls on a weekday, service will be delayed until the next day.


text:
• Hepatic malignancies often infiltrate to the major hepatic vein. Recently, we performed hepatic resection combined with hepatic vein reconstruction for preserving remnant liver function in three such patients. One patient had a saphenous vein graft. Postoperative liver function of the patients who underwent hepatic vein reconstruction was compared with those of eight patients who underwent hepatic resection of segments VII and VIII. The right hepatic vein in four of them was resected and in the remaining four was preserved by skeletalization using an ultrasonic aspirator. Although four patients with right hepatic vein resection showed severe lowering of liver function after surgery, the postoperative course of patients with preservation or reconstruction of the right hepatic vein maintained good liver function. Liver regeneration of three patients with hepatic vein reconstruction was good on computed tomography. Besides this report, to our knowledge, there is no other report of hepatic vein reconstruction for preserving the remnant liver function. Problems with hepatic resection combined with hepatic vein reconstruc tion are discussed. We conclude that hepatic vein reconstruction is one of the means for extending indication of the malignant tumor resection of the liver.
(Arch Surg. 1990;125:1455-1459)
Thank you for submitting a comment on this article. It will be reviewed by JAMA Surgery editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers' bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Need assistance?
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.


text:
WEST DES MOINES — A private wine and cooking class is the prize in a Gallo-sponsored Hy-Vee sweepstakes event. Customers can enter "Cooking with Wine" by filling out an online form on hy-vee.com through June 30. Eight winners will each get to choose either a private wine and cooking class for up to four people at Hy-Vee, or a $250 gift card. The winners will be chosen at random on July 18.
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It's FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Click here to read the FAQ page if you have any questions (opens in a new window)
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.


text:
Don't Expect a Reunion from This '90s Girl Power GroupSuzanne Jannese
I'll tell you what Victoria Beckham wants — what she really, really wants — is to never perform with the Spice Girls again! Despite Mel B recently admitting how she is very "pro Spice," and how she'd love the girl group to get together again on their 20th anniversary in 2014, it seems designer VB isn't so keen.
Victoria dropped the news when she posed for the cover shoot of Vanity Fair Italy and Spain editions. She told the magazine: "I won't ever do it again. Doing the Olympics was an incredible honour. I was so proud to do it; Proud to be British, but it was a perfect time to say, 'This is great, thank you to everybody, but no more.' Sometimes you've got to know when it's time to leave the party."
The successful designer added that although her main passion is fashion, she still feels a connection with her singing days. "The Spice Girls were successful because we celebrated women. That's why I do what I do today."
Victoria's comments came a week after former Spice Girls manager Simon Fuller revealed that none other than Eurythmics star Annie Lennox helped shape the Spice Girls into the chart-topping girl band. He explained in a radio documentary for the BBC, that Annie secretly encouraged him to exaggerate their characters. The girls distinct personas (Sporty, Baby, Scary, Ginger and Posh) helped them become one of the most successful girl bands of all time.
Fuller said:
"Each of the girls knew who they were, and in their own way tried to represent it. It wasn't strong enough, though. Probably the most significant thing that happened, was when they met Annie Lennox. I'm not sure this story has ever been told, and Annie might not thank me for telling it, but I think we were flying to New York when I said, 'I've just signed this girl group.' Annie was very interested. She said, 'I want to meet them'. She was the one who got them to be louder, more brash, and more specific. Emma, who was the sweet blonde girl, became Baby Spice. She just played it up! None of these names actually existed, but Annie gave them focus."
To remind ourselves of the Spice Girls when they first began, here is a pic. (Yes, that is Posh on the left!)
And who they became:
It's a shame we'll never see them Zigazigah again!
Photo credit: Twitter


text:
Get an update on Oklahoma's weather conditions for KOCO Eyewitness News 5's morning meteorologist Brad Sowder.
No email address was supplied by
To complete your registration on this site, please supply an address.
Please confirm or modify the email address to which you will have subscription offers sent.
For a more personalized experience, please supply the following optional information.


text:
Air Force Airframe and Powerplant Certification
An AFAP certification provides aircraft maintenance technicians the opportunity and resources to obtain professional certification through an FAA-approved program. Completion on the program leads to FAA eligibility and certification.
There are three stages necessary to obtain your AFAP Certification.
Lists of AFSC's that are authorized FAA Sign Off.
Individuals authorized for FAA sign-off for Airframe and/or Powerplant certification do not require a CCAF to apply.


text:
DETROIT - The Ford Motor Company is celebrating the fact that its Fusion Hybrid was named "car of the year" by Motor Trend. But the award will bring little comfort to unemployed autoworkers. The Fusion is not made in the United States.
"What's ironic to me, as the years go by, there's less and less union production on the cars being exhibited in the center of this union industry," said United Auto Workers retiree Frank Hammer outside the industry's annual auto show here. "All of them (GM, Ford and Chrysler) are more and more non-union."
Hammer, organizer of the autoworker caravan that traveled to Washington in 2008 to lobby for aid to the auto industry, was joined by other autoworkers and their supporters in a protest outside the North American International Auto Show. The protesters had this message: the auto industry and government must address workers' concerns on jobs, health care, climate change and the need to build the mass transit industry.
The loss of jobs, whether it be to Europe, Asia, South America, or non-union plants here in the United States, is a major reason why Detroit's unemployment rate is almost 50 percent and Michigan's is officially 15 percent and in reality much higher.
The autoworkers also came to counter "tea-baggers" who showed up to protest the appearance of House Speaker Nancy Pelosi and the government's intervention, and use of tax money, to save the auto industry.
"If the tea-baggers had had their way, there would have been no government loans to GM and Chrysler and where would we be? They are not speaking for autoworkers," said Hammer. But he added, loans to GM and Chrysler should be used "for a much faster transformation addressing climate change." The tea-baggers, he noted, are not talking about climate change - "they don't even know it exists."
Conversion of closed plants to other productive uses was on the minds of many. Steve Babson, retired American Federation of Teachers member and former staff member at Wayne State University's Labor Studies Center, said that former autoworkers have tremendous skills that are a valuable resource, even more so than the machinery in the shuttered plants.
"Maybe not so much the equipment but the skills of people working with metal, carbon fiber," Babson said. "That's the vital resource. There are a lot of very big buildings that are empty. But the key resource is workers."
If bailout money goes to banks, it should go with strings attached, he said. "This money should be targeted for investments that are going to rebuild the economy on a sustainable basis."
Wendy Thompson had in mind a specific plant she felt would be ideal for "green" production. Thompson, the past president of UAW Local 235 at American Axle, said axle plants and the equipment they have are suitable for production of windmills.
"Rather than there being a brain drain and everyone forced to leave the area, autoworkers should be getting those jobs," said Thompson.
Ron Lare, who retired in 2008 from the Ford Rouge plant, was particularly upset about health care. The Ford retiree, who worked on the assembly line for 11 years before getting into tool and die, warned that thousands of children formerly covered under the union's insurance program are going to lose health care coverage.
If a child has a grandparent with union retirement benefits who is the child's principal supporter (and the grandparent proves it with a 1040 tax return form), past practice has allowed the child to be covered under the grandparents' health care plan, Lare noted.
"Ford workers just voted down concessions and suddenly we get this sneak attack during the Christmas holiday that the 1040 saying you're the person supporting this child is no longer good enough."
Lare pointed out that a parent would now be forced to give up a child for adoption by the grandparent so coverage would continue.
"We don't know who made this decision - it was probably the VEBA board," he said, referring to the separate board that now manages workers' health benefits.
Contrary to what some people think, the union is a minority on the VEBA board and is not responsible for this cut, said Lare. He added, "It really makes my blood boil because somebody is sitting up in the office making decisions to cut kids off health care."
Glancing over at the tea-baggers, General Baker, longtime UAW activist, commented, "These people over here are opposing the bailout of Chrysler and GM. I think the government did the right thing. iIn fact we should nationalize GM and Chrysler. They got most of it now, take the rest of it and have the government run it because they can't do worse."
As he talked autoworkers were chanting, "Union jobs for you and me, not some lousy cup of tea."
Photo: PW/John Rummel


text:
Celebrity Central / Top 25 Celebs
Kenny Chesney
- 2005
The Chesney-Zellweger Annulment
Zellweger files for an annulment, citing "fraud." Chesney tells PEOPLE in a November 2005 cover story that he has no regrets about marrying Zellweger. "What I did in May, I meant. Isn't it great that kind of love exists?" But he also admits: "I'm sad, I'm angry, and I'm hurt and confused. This is not what I envisioned my life to be six months ago." In response to tabloid rumors about his sexual orientation, Chesney says, "I'm pretty firm in my sexuality and my love for women."
On the Road Again
"I have engulfed myself with work and music," he tells PEOPLE of his latest release, The Road and the Radio, which debuts at No. 1. Despite the success, the Country Music Awards name Chesney's former opening act, Keith Urban, Entertainer of the Year. Chesney goes back on the road. "After the craziness of last year, I didn't think I had the heart to go on the road," he says. "But all of my road family and also my fans, they had the heart for me." The following year, he takes back the CMA for Entertainer of the Year.
- 2007
Poets & Pirates
Seventeen trucks move Chesney's "Flip Flop Summer Tour" from arena to arena. His fifth consecutive summer tour draws more than a million fans. "Believe it or not, I want to keep growing my audience," he tells Billboard. That September, Just Who I Am: Poets & Pirates (right) debuts at No. 1 on the country charts.
CMA's Reigning King
Chesney wins the top award, Entertainer of the Year, at the 2007 CMA Awards. "Guys, I can't believe that I get to stand on the stages I stand on every summer, and get to sing the songs that I sing," he says during his acceptance speech. Chesney is again named Entertainer of the Year at the 2008 CMAs, marking the third consecutive year and fourth time overall he has won the award. The win follows his fourth consecutive Entertainer of the Year award at the Academy of Country Music Awards in May 2008.
- 2012
Friends Forever
Chesney graces PEOPLE's country music issue alongside pal Tim McGraw, who appears on the country star's latest hit "Feel Like a Rock Star." The longtime pals will also trek across the U.S. for their co-headlining "Brothers of the Sun" tour. "I tell you what we won't be doing on tour – love ballad duets!" Chesney tells PEOPLE. "That time of night, in a football stadium, they want it loud and fast. That's what we'll give them."
Photo Credits
BIOGRAPHY (top to bottom): Scott Gries/Getty Images; amazon.com; Scott Gries/Getty
- Name
- Kenny Chesney
- Date of Birth
- March 26, 1968
- Birth Place
- Luttrell, Tenn.
- Relationships
Amy Colley, girlfriend (2008 to present)
Renée Zellweger, ex-wife (2005)
Mandy Weals, ex-girlfriend (1997 to 1999; engaged)


text:
Our team of top-tier therapists
At The Grove, we're attuned to your needs and our qualified team of experienced therapists are here to lend an ear and offer guidance and support. All of our top-tier therapists are fully qualified and accredited by their professional association, such as British Association for Counselling and Psychotherapy (BACP) or registered with United Kingdom Council for Psychotherapy (UKCP) or College of Sexual and Relationship Therapy (COSRT). In working at The Grove, they adhere to the strict code of ethics and are committed to working professionally and confidentially with you. They are equipped to deal with a number of issues that may be troubling you and are available to answer your counselling FAQs anytime.
Ian May
Click here to see Ian May's profile
Louisa Beejay
David Lee


text:
Press Releases | Returned : 5 results
Homestand highlighted by Wille Mac Award, Vin Scully Tribute. Heritage Nights STAR WARS® Day, Oktoberfest, and Fan Appreciation Day
The San Francisco Giants are scheduled to open their 2017 season at the Arizona Diamondbacks on Sunday, April 2 and play their home opener against the Diamondbacks on Monday, April 10, the club announced today.
Homestand highlighted by Pediatric Cancer Awareness Day, Step Up to the Plate Night, Heritage Nights, Fiesta Gigantes and Strike out Violence Day
The San Francisco Giants announced today that single-game ticket availability for potential Postseason games will be limited. Fans are encouraged to register for the opportunity to purchase tickets.
This is a continuation of the inaugural "Childhood Cancer Awareness Day," which Major League Baseball is launching on Friday, September 2nd.


text:
We Are Thinkers, Not Haters
A battle is raging on twitter and in the blogosphere between aid workers and social media darlings. If you are curious just search the hash tag #1MillionShirts. Yesterday @mashable– a wildly popular tweeter/ blogger with almost 2 million followers- put up a link and a post about the 1 Million Shirts campaign. The last I checked it was tweeted 635 times and facebooked 300 times (as tracked on @mashable) with lots of RT's and the occasional pledge to send a shirt. Basically Jason from @iwearyourshirt is going to collect 1,000,000 of your old t-shirts to clothe the people of Africa.
The thing is @mashable moves fast and the story has been quickly buried. If you checked twitter yesterday there was a good balance between support and disapproval. But the aid workers are maintaining momentum and today there are far more people actively tweeting that disapprove of this idea than approve.
The 1 Million Shirts people claim they won't drink the "hatorade" and they are just trying to do good. Maybe in the aid/ development world people are too quick to crush someone's "do good" ideas, but doing good can very quick cause problems. Why crush someone's good intentions? Because aid and community development are about helping people, not making yourself feel good. We need to evaluate every good intention and decide whether or not it is the right thing to do. This does not make you a hater, it makes you a thinker.
Update: It seems Jason is becoming a thinker folks… There is a wonderful interaction between Jason and Siena (@sanstis) on her blog. How can Jason leverage his social media skill set to really do good? It seems he is off to a great start- @iwearyourshirt has almost 22,000 followers and perhaps all eyes are on this battle. The big question is how will it end…
Thinkers research ideas before forming an opinion. For more information check out the following blogs:
Tales From the Hood: 1,000,000 Shirts
Good Intentions Are Not Enough: What Aid Workers Think of the 1 Million Shirts Campaign
Aid Thoughts: The Return of Expert Analysis
Texas In Africa: Some Alternative Ideas to Donating T-Shirts
2 comments
[…] We Are Thinkers, Not Haters – Stratosphere […]
[…] We Are Thinkers, Not Haters – Stratosphere […]
Leave a Comment


text:
Begin Your Search
WineAccess Travel Log
Read stories from the world's greatest wine trails.
More About This Wine
Related Products
Additional Vintages
1999 Domaine de la Vieille Julienne Chateauneuf-du-Pape Reserve
Producer: Domaine de la Vieille Julienne
Style: Red Wine
Grape Type: Rhone Blend
Origin: France
Region: Rhone
Appellation: Chateauneuf du Pape
91(+?) Points | Stephen Tanzer's IWC - January/February 2002
($30) Bright ruby-red. Perfumed aromas of cassis, violet pastille and mint. Dense but juicy and penetrating, with enticing flavors of black fruits, licorice and mint. Tightly wound but already quite aromatic in the middle and on the very long finish. Structured to age. (Europvin/Christopher Cannan Selections, Bordeaux, France)
92 Points | Wine Spectator
95 Points | Robert Parker's The Wine Advocate
Your Rating & Review
1 Member RatingAverage Member Rating: 5.0 out of 5 stars
|5 stars
|4 stars
|3 stars
|2 stars
|1 stars


text:
Beginning this week, you may notice a fresh, new look to the C.A.R. email communications you receive.
C.A.R.'s new appearance for all e-newsletters and e-blasts features new designs, a colorful, modern title, and an easy-to-ready body format. Starting with the April 24 edition of C.A.R. Newsline, the new look will roll out in other C.A.R. communications through the months of April and May.
The redesign was implemented to align the C.A.R. brand with a cleaner, more modern tone, and to offer a faster, easier way for members to absorb e-communication content.
Name *
Please enter your name.
Email *
Please enter a valid email address.
I Like
I Dislike
Cannot login
Broken Link
Message *
Provide us with feedback here.
We are always interested in hearing from you.
Your feedback will help us improve your online experience.


text:
I'm wondering if anyone knows anything about this symbol...letter...stamped in an armoire I just bought. I have enclosed photos of the design on the outside too. I'd like to know age mostly...and value if possible.
It's and English Design. Mfg'er unknown Circa 1930's average value. $200.00 to $250.00 Dollars.
Thanks! I got a deal for $100
Yes you did.


text:
Stay tuned with PennLive.com through all three days of the 2013 NFL draft.
Jeremy Elliott will provide running analysis of the first round and a quick breakdown of picks made by the Baltimore Ravens, Philadelphia Eagles and Pittsburgh Steelers. Look for more analysis and first-round draft grades Friday morning.
Bob Flounders will track Penn State prospects Jordan Hill, Gerald Hodges and Michael Mauti. All three are expected to be picked in the middle rounds, which could be late Friday or anytime Saturday.
Here's a look at what we've done so far:
- PennLive 2013 NFL mock draft
- Sporting News mock draft
- 2013 NFL Draft Big Board: Ranking the class, 1-250
- Five players rising up draft boards
- Security increased in the wake of Boston Marathon bombings
- Eagles news, stats and more
- Draft snapshot: team needs, top candidates, recent history
- Video: Who the Eagles should pick at No. 4
- Elliott: Philadelphia needs to zero in on Central Michigan's Eric Fisher
- Draft rumor: Eagles interested in West Virginia WR Tavon Austin?
- Eagles mock draft roundup
- Poll: What should the Eagles do in the first round?
- Prospect to watch: Eric Fisher, OT, Central Michigan
- Prospect to watch: Star Lotulelei, DT, Utah
- Prospect to watch: Geno Smith, QB, West Virginia
- Prospect to watch: Dion Jordan, OLB, Oregon
- Prospect to watch: Dee Milliner, CB, Alabama
- Ravens news, stats and more
- Draft snapshot: team needs, top candidates, recent history
- Ravens NFL mock draft roundup
- Elliott: Florida safety Matt Elam is a perfect first-round fit in Baltimore
- Video: Who the Ravens should pick at No. 32
- Prospect to watch: Arthur Brown, LB, Kansas State
- Prospect to watch: Manti Te'o, LB, Notre Dame
- Prospect to watch: Robert Woods, WR, USC
- Prospect to watch: Matt Elam, SS, Florida
- Prospect to watch: Kevin Minter, LB, LSU
- Steelers news, stats and more
- Draft snapshot: team needs, top candidates, recent history
- Elliott: Texas safety Kenny Vaccaro fills a defensive need for Pittsburgh
- Poll: What should the Steelers do in the first round?
- Steelers NFL mock draft roundup
- Video: Who the Steelers should pick at No. 17
- Steelers can afford to wait on a running back
- Steelers look to infuse youth, find top-flight running back
- Is tight end Tyler Eifert a no-brainer in the first round?
- Prospect to watch: Eddie Lacy, RB, Alabama
- Prospect to watch: Tyler Eifert, TE, Notre Dame
- Prospect to watch: Jarvis Jones, LB, Georgia
- Prospect to watch: Kenny Vaccaro, DB, Texas
- Prospect to watch: Tavon Austin, WR, West Virginia


text:
ATLANTIC CITY — Atlantic City police can continue to patrol casino parking garages.
A judge on Thursday denied Mayor Lorenzo Langford's request to uphold his executive order banning the patrols until the court decides whether Atlantic County Prosecutor Ted Housel had the authority to void it.
The prosecutor earlier this month said Deputy Police Chief Ernest Jubilee had authority over the department's day-to-day operation.
The Press of Atlantic City reports the judge found the executive order was an attempt to "micromanage" the police department.
The patrols began after a fatal carjacking in the garage of the Trump Taj Mahal Casino Resort last month. The mayor canceled the patrols, saying the officers were needed elsewhere in the city.
The issue will play out in court at a later date.
Related coverage:
• Prosecutor overrules Atlantic City mayor in spat over police patrols of casino parking garages
• Atlantic City mayor tells police not to patrol casino parking garages
• 3rd suspect in Atlantic City fatal casino carjacking arrested


text: Services for Cecil Allen Ring were held at 11 a.m. Monday at Strider Funeral Home with Pastor Harold Newsome officiating. Gail King sang "My Hope is Built" and "Is Your All on the Alter." Miranda Godfrey sang "Amazing Grace, My Chains Are Gone." Interment was at Middleway Masonic Cemetery. Pallbearers were Jacob Manuel, Marc Stephens, Donald Godfrey, Brad Ring, Daniel Sullen and Dave Carper.


text:
Speaker Biographies
Charles Alsdorf, Director, Capital Efficiency Services, Deloitte
Charles is Director in Deloitte Financial Advisory Services LLP, with over 21 years of experience in valuation, strategy, decision analysis and corporate finance. He focuses his practice on evaluating strategic investment decisions in times of volatility and change. He leads Deloitte FAS' practice in capital efficiency, which deploys leading strategy and quantitative methodologies to help companies make optimal decisions in the face of a portfolio of many competing capital funding requests. His experience includes applying multi-attribute decisions analysis to complex portfolio investment challenges, as well as applying decision analysis and real options analysis to major capital projects and transactions. He also co-leads Deloitte FAS' practice in portfolio valuation services for the alternative investment industry including hedge funds and private equity funds. And he is one of the service offering leaders in Deloitte's Enterprise Sustainability program. He has also been selected to participate in Deloitte's Eminence Fellowship program based on his work in capital efficiency. He also serves as a leader in Deloitte's Diversity & Inclusion program. Prior to joining Deloitte FAS, he served as vice president of technology strategy for Standard & Poor's global bond rating agency, and before that as director of valuation for PricewaterhouseCoopers.John Ansell, Senior Partner, Commercial, TranScrip Partners
John Ansell has been an independent pharma industry consultant based in the UK since 1989. Since 2012 he has also been a Senior Partner at TranScrip Partners, a global specialty contract organisation that supports pharma product development and life cycle management. He concentrates on international projects with a commercial and strategic emphasis, reflecting his previous 20 years in the industry in marketing and business development. John advises companies of all sizes including start-ups, as well as those providing services to the industry or investing in it: some 150 clients in all. A Biochemistry graduate with a Masters degree in Business Studies, John Ansell started his career in the industry in Holland with Organon. He subsequently worked for Schering AG and Fisons in the UK, and again in Holland, with Solvay. Lastly, from 1985 to 1989 he worked in international marketing for Glaxo Holdings. Since 2007 he has been an Honorary Consultant to the University of Manchester School of Pharmacy and Pharmaceutical Sciences. John is a frequent speaker and chair at industry conferences. He is also the author of over 50 articles on pharmaceutical issues. His book "Transforming Big Pharma – Considering the Strategic Alternatives" was published by Gower Publishing in 2013 (see www.johnansell.com).Sultan Aziz, Senior Director, Capacity Management, Janssen Pharmaceuticals
Sultan is responsible for providing overall leadership and direction to the Capacity Management department within the PMO. His responsibilities include capacity and demand analyses, operational risk analysis and scenario modeling in support of the Janssen R&D Book-of-Work development pipeline and associated business processes.
Sultan joined JnJ from Merck & Co., where he held key positions of increasing responsibility in R&D Business Operations, Project Management, R&D and Manufacturing Finance. His broad background includes basic research drug discovery and development, launch of several successful products, licensing and acquisitions as well as Over-the-Counter Rx to OTC switches. Sultan holds a MBS in Finance and BA in Biology.
Scott Babler, Strategic Realization Manager, Integrated Project Management Company, Inc.Scott Babler is the Strategic Realization Manager at Integrated Project Management Company, Inc. (IPM), a leading project management consulting firm in life sciences, healthcare and other industries. Mr. Babler has extensive experience in the biomedical (IVT, medical device, combination biologic products), pharmaceutical and biotechnology industries in product management and development, program management, business processes reengineering, quality, design control and regulatory compliance. Leading cross-functional international teams, Mr. Babler has successfully completed programs through project portfolio management, change management, strategic planning, developing processes and implementing best practice techniques for Fortune 500 companies. Mr. Babler holds both a MBA from DePaul University's Kellstadt Graduate School of Business-Chicago and a MA in biochemistry from University of Wisconsin-Madison and University of Kansas-Lawrence. He is certified as a Project Management Professional (PMP) with the Project Management Institute, and as a Six Sigma Black Belt (CSSBB from the American Society of Quality). He recently co-authored and edited an industry text entitled Pharmaceutical and Biomedical Project Management in a Changing Global Environment (Wiley 2010).
Greg Bayer, Group Director, R&D Scheduling & Resource Management, Bristol-Myers Squibb
Greg Bayer leads the R&D Scheduling and Resource Management function in R&D Operations, which is responsible for drug project scheduling, resource & capacity planning and enabling pipeline planning and operations in various settings, including the R&D budget process, the study start approval process, GDOC operations, and others. Prior to his current role, Greg was Director of Global Business Operations in Global Medical, in which he led the annual medical planning process. He joined BMS from the Health & Life Sciences strategy practice at Accenture, where he worked with pharmaceutical industry clients in the areas of R&D governance, resource management, brand strategy, sales acceleration and shareholder value creation. Prior to business school, he worked in a molecular biology research position and as a project manager at a CRO. Greg holds a Bachelors degree in Biology from Wake Forest University and an MBA from the Kenan-Flagler Business School at UNC-Chapel Hill.Richard Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation
Dr. Richard Bayney is President & Founder of Project & Portfolio Value Creation, a consulting boutique providing training and education in project, program, portfolio, resource, and risk management as well as client services in strategic, business, and portfolio planning. He is an adjunct faculty member at the University of Pennsylvania. Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. He obtained his M.Sc. and Ph.D. from University of London, MBA from Columbia University, and PMP from the Project Management Institute.
Joseph Billitti, Ph.D., MBA, Executive Director, Strategy and Operations, Global Research & Development, PfizerJoe is head of Strategy and Operational Effectiveness in the Drug Safety R&D (DSRD) group in the Pfizer Worldwide Research and Development Division. For the past several years he has been on special assignment in the Pfizer Worldwide R&D Business Operations group to lead the Resource and Planning Insights for Decisions (RAPID) project, an integrated operations and business process initiative Pfizer started in 2011. Over his 15 years in the pharmaceutical industry Joe has held positions of increasing responsibility and complexity including leadership roles on drug development teams, key strategic initiatives, and improving R&D effectiveness. Joe holds a Ph.D. in Pharmacology & Toxicology from University of California at Davis where his worked focused on biomarkers. He earned an MBA from University of California at Irvine with specific focus on health care industry issues and policy.
Beau Bush, President, OZMOSIAfter more than a decade working in pharmaceutical new product development, Beau founded OZMOSI out of a drive to help shape the increasingly complex healthcare market. He envisioned a company that could bring clarity and confidence to the investment decisions that shape tomorrow's pharmaceutical products. Beau has a degree in biology from Rutgers University.
Pasquale Cetera, Ph.D., Consultant, MKTG Pharmaceuticals
Pasquale Cetera is a Senior Consultant for the Drug Industry with 33 years of experience in many roles, in Strategic Planning, R&D and Commercial. He was recently responsible for Portfolio Management & Strategy in GHH at Merck; in this position for 6 years, he worked closely with MRL (Merck Research Laboratories) to ensure continuous alignment between commercial and R&D. Before joining Merck, Pasquale was the Head of a Global Franchise in Novartis for three years. Previously, he covered several positions in Marketing and in R&D in Pharmacia/Pfizer. He has been managing the pre-launch and launch activities on many products (Celebrex, Detrol, Enablex, Reclast, Zelnorm, Caverject, Mycobutin, Idamycin, etc.). Pasquale is Italian, although he has worked in the US since 1989; he holds a Ph.D. in Chemistry from Pisa University and an MBA from Bocconi University.Jennifer Daubenspeck, Ph.D., Manager, Reporting and Capabilities, Bristol-Myers Squibb
Jennifer Daubenspeck has been at BMS for 8 years and currently supports two Planisware systems: ePlan, the scheduling and resource forecasting system for R&D, and eTime, the time tracking system. She leads the Business Working Group for eTime, and supports 200 coordinators and more than 6000 users. In ePlan, Jennifer has worked with resource management and functional areas to develop and maintain resource forecasting algorithms for roles on pharmaceutical development teams and clinical teams. Prior to BMS, Jennifer was an assistant professor at the University of San Diego. Jennifer holds a PhD in Industrial Engineering from Lehigh University, and a bachelor's in Mathematics from Penn State.Jeffrey Davis, M.D., Director, Human Health and Performance (HH&P), CMO, NASA Johnson Space Center
Jeffrey R. Davis, M.D., MS currently serves as Director, Human Health and Performance (HH&P) and as the Chief Medical Officer for the NASA Johnson Space Center. The HH&P Directorate provides the research and technology development required for exploration as well as all human health and performance support to space flight operations of the International Space Station. Dr. Davis serves as the Director, NASA Human Health and Performance Center (NHHPC), a collaborative organization of over 135 members across government, industry, academia and non-profit organizations; and Deputy Director of the Center of Excellence for Collaborative Innovation (CoECI), a collaborative center to promote the use of prizes within the federal government. Dr. Davis received his B.S. degree in Biology from Stanford University and M.D. degree from the University of California at San Diego. He also holds a Master of Science (MPH equivalent) degree from Wright State University. His residency training included internal medicine and aerospace medicine, and he is certified by the American Board of Preventive Medicine.
Melquiades (Mel) de Jesus, Director, Business Capabilities, R&D Operations,
Bristol-Myers Squibb
Mel leads the business process design and operational support team for the
Planisware system (ePlan & eTime) at BMS. The group's intent is to
maximize the value of this enterprise project, resource management and time
tracking tool across the organization by developing sustainable and scalable
business processes that leverage the technical solutions while minimizing the
cost of the system ownership. Prior to joining BMS, he worked at Abbott,
PriceWaterHouseCoopers consulting group and Merck. In the first half of
his career, Mr. de Jesus supported four new product introductions by leading
the technology transfer process from scale-up to pre-approval inspections at
the Puerto Rico facilities. In the second half, he was involved in five
enterprise-wide business process standardization initiatives from paperless
manufacturing system to an enterprise-wide project management and portfolio
management tool. Mr. de Jesus earned his MBA from Columbia Business School,
with a focus on finance and operations, and his Pharmacy undergraduate degree
from Rutgers University. He lives in Yardley Pennsylvania with wife Stephanie,
their 8-year-old daughter, Sophia Rosa and 4-year daughter, Olivia Jasmine.
Sydney Edwards, Ph.D., Head, Portfolio Management, Allergan, Inc.Sydney Edwards is the Head of Portfolio Mgmt at Allergan. In this position, he plays a leading role in setting strategic priorities for new medical therapies to better serve patients. He is the former global team leader for development of LATISSE®, a $100M Dermatology product. He is a leading expert in applying Lean Startup & Accelerator approaches to the search and development of therapeutic drugs. Prior to Allergan, he was a venture capitalist with TL Ventures, where he led startup investment funding in Barrier Therapeutics, a dermatology company later acquired by Stiefel Labs for $148M. He obtained his Bachelor's degree in Biochemistry from UC Berkeley, a PhD in Biochemistry from the Pennsylvania State University and MIT Sloan School MBA. He was awarded the MIT Martin Trust Fellowship for excellence in fostering entrepreneurship in the MIT Community.Carmel Egan, Ph.D., Vice President, Project Management, Eli Lilly & Co.
J. Carmel Egan, Ph.D., was named vice president of project management for Lilly in March 2005. Prior to that, she had been vice president, manufacturing science and technology since 2001. She had been executive director of product development since July 2000. She is a member of the senior management council. Born in Ireland, she received a Bachelor of Science degree in chemistry from University College, Cork, in 1980 and a doctorate in chemistry in 1984 from the University College, Dublin. She joined Lilly in 1986 at the affiliate in Kinsale, Ireland, following an industrial postdoctoral fellowship in Puerto Rico. In 1990, she transferred to the United States at Clinton Laboratories as group leader of technical services. Egan moved to corporate headquarters in Indianapolis as manager of development projects management in 1992. She was named head of chemical process research in 1995 and the next year was named manager of regulatory affairs: chemistry, manufacturing and control. She was named director, development projects management in 1997. The next year, she became the program team leader for SERM III, and the following year was named product team leader for SERM III. In July 2000, she was named executive director of product development. She was a recipient of the 1999/2000 Chairman's Ovation Award. Sponsored by Sidney Taurel, chairman and chief executive officer, the award is presented annually to a select number of leaders who demonstrate an exceptional ability to motivate and develop people.Philip Fahringer, Analyst, Center for Innovation, Lockheed Martin
Philip A. Fahringer is an Operations Analyst with over 27 years of combined experience in the military and industry. He has focused his analysis on developing strategic decision support applications. These applications enable decision makers to factor in uncertainty around their assumptions and then make analytically based decisions regarding which courses of action will yield the best resultsin their judgment under the widest range of likely scenarios. The results are presented in terms of overall performance expectations, overall costs, performance risk and budget risk. Currently, he is the lead developer for the Dynamic Comparative Analysis Methodology for Lockheed Martin.Jonathan Freeman, Ph.D., Senior Vice President, Head of Portfolio Management, Merck Serono
Jonathan is since 2012 SVP Head of Global Portfolio Management, Global Business Development & Strategy; previously he was Head of Licensing, Global Business Development. Before Rejoining Merck Serono in 2008 Jonathan was Director, Licensing and M&A (Europe/ECEMEA)at Baxter Healthcare from 2006. In 2000 he started at Serono as Director, Licensing & Strategy. He is a graduate from the University of Cambridge(UK) and has a Ph.D from the University of Edinburgh (UK).Krish Ghosh, Ph.D., Vice President, Informatics, Covance
Krish Ghosh is Vice President of Informatics at Covance, and serves as a member of the Informatics Executive Management team reporting to the CDO of the company. Prior to this, Krish was the Vice President of Global Resource Management and reported to the CFO. Krish joined Covance in May of 2006. He is responsible for leading Global Informatics activities. He has developed innovative methods and solutions to help drive value in the drug development continuum, business performance/expansions, and supported the growth, capacity management, expansion efforts, and profitability of the company. In addition, Krish has 13 years of Pharmaceutical industry experience and 4 years in academics. He was the Director of Project Planning and Information at Wyeth and held different positions in R&D at BMS. Krish holds a Ph.D. in Statistics and an MBA in Finance from Temple University.Arkady Gusev, Ph.D., US Operations Head, Biomarker Development (BMD), Translational Medicine, Novartis Institutes for BioMedical Research, Inc.
Dr. Arkady Gusev is currently a head of US Operations in Biomarker Development, Translational Medicine of Novartis Institute of Biomedical Research. From 2002 to 2009 Arkady Gusev led the Business and Technology Operations unit in the Department of Pharmacokinetics, Dynamics and Metabolism in Pfizer Global Research Division. Arkady Gusev research interests include analytical instrumentation, project and portfolio management, clinical biomarker development and utilization, clinical outsourcing, operational excellence and regulatory compliances.Ling He, Ph.D., Director, Clinical Bioanalysis, Clinical Pharmacology and Translational Medicine, Daiichi Sankyo Pharma Development
Ling He is currently the head of Clinical Bioanalysis Daiichi Sankyo Pharma Development. His function supports regional and global clinical development programs from phase 1 to 3. Since joining pharma industry in 1997, Ling has worked in multiple organizations (Schering Plough, QPS and Daiichi Sankyo) and at different stages of drug R&D (discovery, preclinical and clinical), and supported multiple drug filings. As a scientist his research interests/expertise includes regulated bioanalysis, drug metabolism and clinical pharmacology. Ling received his Ph.D. degree in Analytical Chemistry at University of Michigan.Hartmut Hein, Ph.D., Director, Global Planning Office, Merck KGaA
Hartmut has more than 10 years experience in project management. After receiving his Ph.D. in Chemistry he started in 1999 in process development. Over the years he held various positions with increasing responsibility as CMC-Leader, in Manufacturing and Clinical R&D. With the merger of Merck KGaA and Serono S.A. he was part of a team setting up Project Management for Merck Serono heading the PMO function. With the reorganization of Merck Serono initiated in 2012 he took over the Global Planning Office to establish global standardization for Project Management and Resource Management.Rafiqul Islam, Senior Director, Global Bioanalytical Services, Celerion, Inc.
Rafiqul Islam is the Senior Director of Bioanalytical Services at Celerion, Inc. In his current role he is be responsible for the scientific and operational leadership for both small and large molecule bioanalysis. He is also responsible for developing and executing a strategic plan to deliver scientific, operational and service excellence to Celerion clients. Previously, Rafiq held positions at EMD Millipore where he was the Scientific Director for Biopharma Services. He held similar positions at Covance and Huntingdon Life Sciences. He also held several positions of increasing responsibility with Curagen Corporation. He has 14 years of industry experience.Elayne Ko, Director, Portfolio and Decision Analysis, Pfizer Inc
Elayne Ko is the Director of the Portfolio and Decision Analysis group at Pfizer. She was formerly a Manager in the Strategy Group of Siemens' Health Services (HS) Business Unit focusing on portfolio management and business planning. Prior to Siemens, Elayne worked as a Manager at Deloitte Financial Advisory Services LLP to support client decision-making under risks, uncertainties and multiple objectives in the mining, financial services and pharmaceuticals. Before Deloitte, Elayne spent 7 years at Pfizer's Portfolio and Decision Analysis (PDA) group where worked extensively on drug research and development investment decisions, long-term strategic planning, and disease area prioritization. Her project experiences spanned across a number of therapeutic areas including infectious diseases, neuroscience, urology, pain, oncology and cardiovascular. Elayne holds a BS in Management Sciences and MS in Decision Sciences from The London School of Economics.William Korinek, Ph.D., Vice President, Worldwide R&D Business Operations, Pfizer
Dr. William Korinek is currently Vice President, Worldwide R&D Business Operations at Pfizer. He joined Pfizer in 2005 and has advanced through a number of strategic and operational positions driving short and long term R&D productivity improvements. Dr. Korinek managed the R&D Program Management Office (PMO) for the Pfizer-Wyeth integration, and led the PMO for Pfizer WRD's 2011 "Engine for Sustainable Innovation" strategic restructuring involving the reduction of Pfizer's overall R&D 2012 spend from $8.0-8.5B to $6.5-7.0B. As Head of WRD Business Operations, he is leading the integration of business operations, processes, and related systems across R&D to optimize project planning, resource management, financial forecasting, and portfolio delivery. Dr. Korinek previously worked as an Engagement Manager at the strategy consulting firm L.E.K. Consulting, where he worked with over 40 biotech and pharmaceutical companies on issues such as strategic planning, portfolio prioritization, and M&A due diligence. He earned his Ph.D. in Biochemistry from Harvard University's Molecular and Cellular Biology Department, and has published in leading journals including Science.Simone Kraemer, Ph.D., Associate Director, Reporting Capabilities, Bristol-Myers SquibbSimone Kraemer is Assoc. Director, Business Capabilities in R&D Operations at Bristol-Myers Squibb. In her current role she is responsible for the Planisware System, an enterprise planning tool used to support project and portfolio management in R&D Operations, with special emphasis on developing and enhancing the application to optimally support timeline and resource management. Before joining the Business Capabilities group in 2010, Simone worked in different roles in or supporting directly Global Clinical Operations. Simone holds a PhD in Biology from Eberhardt-Karls-Universität Tübingen, Germany.John LaMattina, Senior Partner, PureTech Ventures
Dr. John L. LaMattina is the former Senior Vice President, Pfizer, Inc. and President, Pfizer Global Research and Development. In this role, Dr. LaMattina oversaw the drug discovery and development efforts of over 12,000 colleagues in the United States, Europe and Asia. He retired from this position in December, 2007. Dr. LaMattina spent 30 years at Pfizer Inc having joined as a medicinal chemist in 1977. Over the years, he held positions of increasing responsibility for Pfizer Central Research, including Vice President of US Discovery Operations in 1993, Senior Vice President of Worldwide Discovery Operations in 1998 and Senior Vice President of Worldwide Development in 1999. During his tenure as head of global R&D, Pfizer produced new treatments for cancer, smoking cessation rheumatoid arthritis and AIDS. Dr. LaMattina is the author of numerous scientific publications and holds a number of U.S. patents. In addition, he is the author of "Drug Truths: Dispelling the Myths About Pharma R&D" and "Devalued and Distrusted – Can the Pharmaceutical Industry Restore Its Broken Image?" He is also a contributor to Forbes.com. Dr. LaMattina is a Senior Partner at PureTech Health. He serves on the Board of Directors of Ligand Pharmaceuticals, Ziarco Pharmaceuticals, Zafgen, and the Scientific Advisory Board of Trevena Pharmaceuticals. Dr. LaMattina also serves on the Board of Trustees of Boston College where he chairs the Academic Affairs Committee.Sam Mathew, MBA, Portfolio Capacity Management Leader, Finance/PMO, Janssen Pharmaceuticals
Sam Mathew (MBA, LSS BB, CEM, PMP), is a Portfolio Capacity Management Leader at Janssen Pharmaceuticals. He has over 18 years' experience in pharmaceutical, R&D and management consulting, with particular focus on executive decision support, insightful information and analysis, forecasting, visualization, analytics and modeling. He has led internal and management consulting initiatives and teams at Merck, Accenture, Pfizer, BMS, Amgen, PepsiCo and Apple Computers.Maureen McNamara, Executive Director, Global Project Management, Merck Research Laboratories
Maureen is an Executive Director in Global Project Management at Merck Research Laboratories. She has over 25 years' experience in drug development including leading product development teams, portfolio and pipeline prioritization efforts and developing and mentoring Project Managers in the art of drug development project management. Maureen's portfolio expertise spans discovery through life cycle management. She has been involved in decision making at the therapeutic area level and across therapeutic areas at the project and study levels. At Merck she was instrumental in the Merck and Schering Plough merger and the rapid integration of the two portfolios. From that point she led the portfolio decision making within the Global Scientific Strategy organization which was responsible for deciding the Discovery and Early Development portfolio. More recently Maureen led the portfolio decision making in collaboration with finance, commercial and manufacturing for the Late stage portfolio as part of the company reorganization and refocusing of priorities. Maureen holds a BS in Chemistry from the College of St Elizabeth and an MBA from Seton Hall University.Carlos Nunes, Director, Portfolio & Decision Analysis, Pfizer
Carlos reports into the Portfolio, Strategy & Commercial Operations function at Pfizer where he is responsible for the cross-business medicine development portfolio management office. Involved in this practice is the maintenance of valuation standards for internal clinical development programs and business development opportunities; the management of the repository of current and historical portfolio valuations; and enterprise support for portfolio investment analytics. Carlos has 16 years with Pfizer, with service spanning multiple roles across Research, Development and Commercial disciplines and specializations in Informatics, Business Intelligence, Project and Resource Management and more recently in Project Valuation and Portfolio Investment Decision Support.
David Parker, Ph.D., Vice President, Market Access Strategy, Precision for MedicineDavid Parker, PhD, is the Vice President of Market Access Strategy at Precision for Medicine. David has over 25 years of experience in the healthcare industry, including 16 years of strategy consulting experience centered on the intersection of reimbursement, health economics, clinical science, and marketing strategy. His consulting encompasses all aspects of reimbursement, market access, and evidence development strategy with a particular focus on personalized medicine, molecular and advanced diagnostics, and medical devices. Throughout his career, David's work has resulted in numerous successful product launches, guided major investment and acquisition decisions, and driven favorable coverage and payment determinations by public and private payers alike. His consulting career was preceded by 11 years of increasingly responsible product and marketing management, strategic planning, and business development roles at biotechnology companies ranging from development-stage to units of Fortune 500 businesses. David is a frequent speaker and the author of peer-reviewed publications as well as book chapters in the biomedical sciences and health economics. David received his A.B. degree in Biochemistry from Princeton University and his PhD in Cell and Developmental Biology from the Massachusetts Institute of Technology, where he was a National Science Foundation Fellow.
John Phillips, Director, Capital Efficiency, Business Valuation Consulting, Deloitte Transactions & Business Analytics
John Phillips is a Director in the Business Valuation Consulting practice of Deloitte Transactions & Business Analytics. John's expertise is in assisting Life Science and Healthcare clients in strategic decision making pertaining to portfolio optimization, M&A/L&A, risk assessment and business valuation. John has worked nationally and internationally with clients in the pharmaceuticals, medical device, diagnostics, health care delivery, and health care insurance industries. Prior to joining Deloitte, John spent 28 years in the Life Sciences industry in management roles in R&D, Sales, New Product Development, and Strategic Marketing.
William Ramos, Executive Consultant, Planisware USAWilliam Ramos is a solution architect and an executive implementation consultant. For over 12 years, William has been helping life science organizations translate project and portfolio management business processes into practical solutions within Planisware software, overseeing all aspects of implementation from requirements gathering to system delivery and adoption. His time at Planisware has afforded him deep knowledge of industry best practices and front-line experience with what works and what doesn't in portfolio and resource management. William holds a master's degree of industrial engineering from the Arts & Metiers Paris Tech graduate school.
George Santangelo, Ph.D., Head, Office of Portfolio Analysis (OPA), Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), NIH
Dr. George Santangelo is the Director of the Office of Portfolio Analysis (OPA/DPCPSI/OD). George received a B.A. in Molecular Biology from the University of Pennsylvania and a Ph.D. in Genetics from Yale University. He did his postdoctoral work on two University of California campuses (Irvine and Santa Cruz), and from 2000 to 2009 was Professor of Biological Sciences at the University of Southern Mississippi. His NSF-and NIH-funded research has focused on glucose signaling and the role of nuclear organization in transcriptional regulation. His research output includes a 2005 paper in the Proceedings of the National Academy of Sciences that was designated a "Must Read" by the Faculty of 1000 and featured in The Scientist that same year in an article entitled "A Nuclear Model of Gene Regulation."
Michael Shires, Vice President, Program and Portfolio Management, Baxter Healthcare
Mike Shires role within Baxter is Vice President of Program and Portfolio Management for Baxter's BioScience Business. Mike is responsible for the Project Management Function including Policies, Practices and Resourcing. Mike is a member of the BioScience Senior Management Team reporting to the BioScience President. Mike chairs the Baxter Project Management Council, which includes representatives from all Baxter businesses. Mike is directly responsible for the planning and execution of the New Product Development, Operations and Launch Pipeline of projects for the Baxter BioScience business. In the portfolio elements of his job – Mike is responsible for the Prioritization and Analytical Analysis of those projects. Prior to Baxter, Mike successfully developed and led the Project Management Offices for Divisions of Motorola and 3Com. He started his career in the Aerospace Industry with the US Government and Lockheed-Martin. His last assignment in this industry was as the Project Lead for the then largest international sale of military aircraft. Mike is married, with two children.
Richard Sonnenblick, Ph.D., CEO, Enrich Consulting
Richard Sonnenblick, the CEO of Enrich Consulting, has been with Enrich since its inception in 1998. The vision he brought to Enrich has been realized in the Enrich Analytics Platform. Prior to founding Enrich, he built a decision analysis consulting practice at Lumina Decision Systems, where he worked on integrated assessments of environmental legislation and R&D valuation models for high technology firms. Dr. Sonnenblick holds a Ph.D. and MS from Carnegie Mellon University in Engineering and Public Policy, and a BA in Physics from the University of California, Santa Cruz.Tom Stone, Lecturer in Business, Penn State University, Abington College
Tom Stone is a Lecturer in Business at Penn State University, Abington College. He was formerly Director in Siemens Health Services Strategy group, with principal focus on Benchmarking activities. With Siemens for the past 23 years, Tom has applied his financial skills in a variety cross functional settings. Primary responsibilities have included a broad range of topics including financial analysis and controlling, strategic / business planning, project management, benchmarking, competitive analysis, compliance and transfer pricing. Tom has executed these responsibilities in both US and International departments. Prior to Tom's current role in Strategy, his most recent responsibilities included Financial Officer for Health Services International, a $30M US-based portfolio for emerging markets, and earlier served as Director of the Strategic Projects Office which, in conjunction with the Boston Consulting Group, directed the planning and execution of major strategic initiatives targeting specific productivity gains and over 5-year strategic plan.Bennet Vallet, Director, Product Development, Siemens
Bennet Vallet has been at Siemens Health Services for over 20 years and is a Director of Product Development where he leads the Agile Center of Competency. Previous to that Bennet held multiple leadership roles within the company's Product Lifecycle Management (PLM) organization where he has been involved continuously in the development of large scale healthcare information systems. Bennet has been involved in leading agile transformations since 2005, the year the company adopted Scrum/XP. In addition to his current management responsibilities, Bennet is the agile strategist on the company's product development excellence team, chartered to drive key improvement initiatives with respect to people, process and infrastructure. In this capacity Bennet is currently driving the company's adoption of key change initiatives including the rollout of Kanban and the training and development of Agile coaches.Phil Wolf, Senior Vice President, Enterprise and On Demand Products, PDWareDaniel Zweidler, Ph.D., Senior Fellow, Mack Institute for Innovation Management, The Wharton School, UPenn; President, DZA, Inc.
Dr. Daniel Zweidler is a leading strategy and portfolio optimization expert, who is also known as a futurist and a champion of open innovation and co-creation. Dr. Zweidler helps energy and health care organizations make better investment decisions by blending scenario planning, strategic thinking and portfolio option planning techniques. He has an exceptional ability to bridge cross-cultural, multi-national differences in collaborative team environments as a result of a career that spans 20+ countries across six continents and his multi-lingual fluency.
Dr. Zweidler is currently a Senior Fellow at the Mack Center for Technological Innovation and is President of Daniel Zweidler & Associates, a boutique management-consulting firm. Prior to that, Dr. Zweidler was SVP at Merck & Head of Portfolio Management/Global Scientific Strategy. He previously had been at Royal Dutch Shell, holding diverse roles such as Head of Global Exploration Planning & Portfolio, Exploration Planning and Portfolio Manager, and Senior Exploration Consultant, after starting with the firm as an Exploration Geologist in The Hague, Netherlands. Dr. Zweidler studied at Université de Neuchâtel in Switzerland, where he received both his master's and his doctorate in geology. He lectured extensively on the subject of strategic thinking and portfolio option planning as part of Shell's executive education program at the Judge Business School, University of Cambridge. Dr. Zweidler has presented numerous papers in both academic and industry settings, and co-authored the foundational paper on Probability Management in OR/MS Today. He is a member of the Long Now Foundation, the Institute for Operations Research and the Management Sciences, the American Association of Petroleum Geologists and the Swiss Geological Society. He also served as president of the Swiss American Society of New Orleans between 1997 and 2000. Dr. Zweidler is committed to identifying socially responsible strategies that help organizations maximize value, increase capital efficiency, and reduce enterprise risk while optimizing investments in their Innovation, R&D, and Exploration portfolios.
Premier Sponsors:
Corporate Sponsors:
Corporate Support Sponsors:
Conference At-A-Glance View All Sponsors View Media Partners